Suanfarma Suanfarma

X

Find VS-5584 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

VS-5584
Also known as: Vs-5584, 1246560-33-7, Vs-5584 (sb2343), Sb2343, Sb-2343, 5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine
Molecular Formula
C17H22N8O
Molecular Weight
354.4  g/mol
InChI Key
QYBGBLQCOOISAR-UHFFFAOYSA-N
FDA UNII
W71J4X250V

PI3K/mTOR Kinase Inhibitor VS-5584 is a potent and selective inhibitor of both phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR kinase inhibitor VS-5584 inhibits mTOR kinase and all class I PI3K isoforms. Consequently, this disrupts phosphorylation of substrates downstream of PI3K and mTOR and may result in apoptosis and growth inhibition in susceptible tumor cells. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy. mTOR is a serine/threonine kinase downstream of PI3K, which also has PI3K-independent activity. Consequently, this agent may potentially be more potent than an agent that inhibits either PI3K kinase or mTOR kinase.
1 2D Structure

VS-5584

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine
2.1.2 InChI
InChI=1S/C17H22N8O/c1-10(2)25-11(3)21-14-13(12-8-19-16(18)20-9-12)22-17(23-15(14)25)24-4-6-26-7-5-24/h8-10H,4-7H2,1-3H3,(H2,18,19,20)
2.1.3 InChI Key
QYBGBLQCOOISAR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=NC2=C(N=C(N=C2N1C(C)C)N3CCOCC3)C4=CN=C(N=C4)N
2.2 Other Identifiers
2.2.1 UNII
W71J4X250V
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9h-purin-6-yl)-pyrimidin-2-ylamine

2. Sb2343

3. Vs-5584

2.3.2 Depositor-Supplied Synonyms

1. Vs-5584

2. 1246560-33-7

3. Vs-5584 (sb2343)

4. Sb2343

5. Sb-2343

6. 5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine

7. Chembl3393066

8. W71j4x250v

9. Vs5584

10. 5-[9-isopropyl-8-methyl-2-(morpholin-4-yl)purin-6-yl]pyrimidin-2-amine

11. 2-pyrimidinamine, 5-(8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9h-purin-6-yl)-

12. 2-pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9h-purin-6-yl]-

13. Unii-w71j4x250v

14. Schembl539098

15. Gtpl8382

16. Dtxsid10677328

17. Ex-a288

18. Vs 5584 [who-dd]

19. Hms3652b16

20. Bcp08247

21. Wzb56033

22. Bdbm50059635

23. Mfcd25372027

24. Nsc778810

25. Nsc800991

26. S7016

27. Zinc95644685

28. 5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9h-purin-6-yl)-pyrimidin-2-ylamine

29. Akos024465057

30. Ccg-268087

31. Cs-1202

32. Db12986

33. Nsc-778810

34. Nsc-800991

35. Sb 2343

36. Sb16877

37. 5-[8-methyl-2-(morpholin-4-yl)-9-(propan-2-yl)-9h-purin-6-yl]pyrimidin-2-amine

38. Ncgc00386370-03

39. Ncgc00386370-06

40. Ac-33121

41. As-80075

42. Da-46738

43. Hy-16585

44. Ft-0700143

45. Sw220201-1

46. A857790

47. J-690096

48. Q27089164

49. 5-(8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9h-purin-6yl)-2-pyrimidinamine

50. 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9h-purin-6-yl]-2-pyrimidinamine

2.4 Create Date
2010-10-18
3 Chemical and Physical Properties
Molecular Weight 354.4 g/mol
Molecular Formula C17H22N8O
XLogP30.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count3
Exact Mass354.19165736 g/mol
Monoisotopic Mass354.19165736 g/mol
Topological Polar Surface Area108 Ų
Heavy Atom Count26
Formal Charge0
Complexity466
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY